Compounding—Important Developments That Will Affect Your Practice

Monday, October 20, 2014, 8:00 am - 9:30 am
Austin Convention Center
Location: 17AB, Level 4
Continuing Education Credits: 1.5 (0.15 Contact Hours)
ACPE #: 207-000-14-223-L03-P and ACPE #: 207-000-14-223-L03-T

Vital information for all compounders! The implementa¬tion of DQSA is underway, bringing significant changes in compounding that will affect your business. This session will give insight on implementation of the new outsourcing facility category as well as further guidance regarding traditional compounding and one state's approach to the new law. Additionally, the pro¬gram will feature an update from USP, including the recently proposed chapter on the handling of hazardous drugs.

Pharmacist and Technician Learning Objectives:

  1. Summarize developments in the implementation of Drug Quality and Safety Act (DQSA)

  2. Discuss FDA's actions on the newly created outsourcing facility classification.

  3. Explain the provisions in USP General Chapter <800> and its implications for community practice compounders.

Speaker: Gay Dodson, Executive Director of the Texas State Board of Pharmacy, Austin, Texas; David Miller, Executive Vice President and CEO, IACP, Alexandria, Virginia; Jeanne Sun, USP, Rockville, Maryland

Categories:
Activity Type: Application-based
Audience: Pharmacists and Pharmacy Technicians

Handout